Home/Pipeline/Autoimmune Diagnostics Leadership Initiative

Autoimmune Diagnostics Leadership Initiative

Autoimmune Diseases

CommercialActive

Key Facts

Indication
Autoimmune Diseases
Phase
Commercial
Status
Active
Company

About Vibrant America Clinical Laboratory

Vibrant America is a commercial-stage clinical laboratory specializing in high-volume, automated diagnostic testing. It has positioned itself as a cost-effective provider with a rapidly expanding test menu, notably gaining FDA Emergency Use Authorization for COVID-19 serum and dried blood spot tests and achieving New York State accreditation. The company's strategy centers on technological innovation in multiplex testing and automation to drive down costs and improve turnaround times, aiming to become a leader in the autoimmune diagnostics segment while serving a national client base.

View full company profile

Other Autoimmune Diseases Drugs

DrugCompanyPhase
Humira (Adalimumab) BiosimilarNeuCloneEarly Preclinical
HBM7020Harbour BioMedDiscovery
R2006Harbour BioMedDiscovery
R7027Harbour BioMedDiscovery
ImmCelz™ PlatformCreative Medical Technology HoldingsPreclinical
Not specified in provided content3SbioVarious
Gavocabtagene autoleucelastellasPhase 1/2
TYK-101TYK MedicinesPhase 1
HCB206HanchorBioPreclinical
miR-124 ActivatorFormation BioPhase 2
Autologous Cell Therapy CollaborationLupagenPreclinical
I&I PortfolioThird Arc BioPre-clinical